Chapter/Section Purchase

Leave This Empty:

Global Ketorolac Injection Market Insights and Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Ketorolac Injection Product Introduction
1.2 Market by Type
1.2.1 Global Ketorolac Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 15mg/ml
1.2.3 30mg/ml
1.3 Market by Application
1.3.1 Global Ketorolac Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Recovery Center
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ketorolac Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Ketorolac Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Ketorolac Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ketorolac Injection Sales by Region
2.4.1 Global Ketorolac Injection Sales by Region (2017-2022)
2.4.2 Global Sales Ketorolac Injection by Region (2023-2028)
2.5 Global Ketorolac Injection Revenue by Region
2.5.1 Global Ketorolac Injection Revenue by Region (2017-2022)
2.5.2 Global Ketorolac Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ketorolac Injection Sales by Manufacturers
3.1.1 Global Top Ketorolac Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Ketorolac Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ketorolac Injection in 2021
3.2 Global Ketorolac Injection Revenue by Manufacturers
3.2.1 Global Ketorolac Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Ketorolac Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ketorolac Injection Revenue in 2021
3.3 Global Ketorolac Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ketorolac Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ketorolac Injection Sales by Type
4.1.1 Global Ketorolac Injection Historical Sales by Type (2017-2022)
4.1.2 Global Ketorolac Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Ketorolac Injection Sales Market Share by Type (2017-2028)
4.2 Global Ketorolac Injection Revenue by Type
4.2.1 Global Ketorolac Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Ketorolac Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ketorolac Injection Revenue Market Share by Type (2017-2028)
4.3 Global Ketorolac Injection Price by Type
4.3.1 Global Ketorolac Injection Price by Type (2017-2022)
4.3.2 Global Ketorolac Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ketorolac Injection Sales by Application
5.1.1 Global Ketorolac Injection Historical Sales by Application (2017-2022)
5.1.2 Global Ketorolac Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Ketorolac Injection Sales Market Share by Application (2017-2028)
5.2 Global Ketorolac Injection Revenue by Application
5.2.1 Global Ketorolac Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Ketorolac Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ketorolac Injection Revenue Market Share by Application (2017-2028)
5.3 Global Ketorolac Injection Price by Application
5.3.1 Global Ketorolac Injection Price by Application (2017-2022)
5.3.2 Global Ketorolac Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ketorolac Injection Market Size by Type
6.1.1 North America Ketorolac Injection Sales by Type (2017-2028)
6.1.2 North America Ketorolac Injection Revenue by Type (2017-2028)
6.2 North America Ketorolac Injection Market Size by Application
6.2.1 North America Ketorolac Injection Sales by Application (2017-2028)
6.2.2 North America Ketorolac Injection Revenue by Application (2017-2028)
6.3 North America Ketorolac Injection Market Size by Country
6.3.1 North America Ketorolac Injection Sales by Country (2017-2028)
6.3.2 North America Ketorolac Injection Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Ketorolac Injection Market Size by Type
7.1.1 Europe Ketorolac Injection Sales by Type (2017-2028)
7.1.2 Europe Ketorolac Injection Revenue by Type (2017-2028)
7.2 Europe Ketorolac Injection Market Size by Application
7.2.1 Europe Ketorolac Injection Sales by Application (2017-2028)
7.2.2 Europe Ketorolac Injection Revenue by Application (2017-2028)
7.3 Europe Ketorolac Injection Market Size by Country
7.3.1 Europe Ketorolac Injection Sales by Country (2017-2028)
7.3.2 Europe Ketorolac Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ketorolac Injection Market Size by Type
8.1.1 Asia Pacific Ketorolac Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Ketorolac Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Ketorolac Injection Market Size by Application
8.2.1 Asia Pacific Ketorolac Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Ketorolac Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Ketorolac Injection Market Size by Region
8.3.1 Asia Pacific Ketorolac Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Ketorolac Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Ketorolac Injection Market Size by Type
9.1.1 Latin America Ketorolac Injection Sales by Type (2017-2028)
9.1.2 Latin America Ketorolac Injection Revenue by Type (2017-2028)
9.2 Latin America Ketorolac Injection Market Size by Application
9.2.1 Latin America Ketorolac Injection Sales by Application (2017-2028)
9.2.2 Latin America Ketorolac Injection Revenue by Application (2017-2028)
9.3 Latin America Ketorolac Injection Market Size by Country
9.3.1 Latin America Ketorolac Injection Sales by Country (2017-2028)
9.3.2 Latin America Ketorolac Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ketorolac Injection Market Size by Type
10.1.1 Middle East and Africa Ketorolac Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ketorolac Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Ketorolac Injection Market Size by Application
10.2.1 Middle East and Africa Ketorolac Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ketorolac Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Ketorolac Injection Market Size by Country
10.3.1 Middle East and Africa Ketorolac Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ketorolac Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Almaject
11.1.1 Almaject Corporation Information
11.1.2 Almaject Overview
11.1.3 Almaject Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Almaject Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Almaject Recent Developments
11.2 Amphastar
11.2.1 Amphastar Corporation Information
11.2.2 Amphastar Overview
11.2.3 Amphastar Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amphastar Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amphastar Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius Kabi Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Hikma
11.4.1 Hikma Corporation Information
11.4.2 Hikma Overview
11.4.3 Hikma Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hikma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hikma Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Sagent
11.6.1 Sagent Corporation Information
11.6.2 Sagent Overview
11.6.3 Sagent Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sagent Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sagent Recent Developments
11.7 Alvogen
11.7.1 Alvogen Corporation Information
11.7.2 Alvogen Overview
11.7.3 Alvogen Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Alvogen Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Alvogen Recent Developments
11.8 Athenex
11.8.1 Athenex Corporation Information
11.8.2 Athenex Overview
11.8.3 Athenex Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Athenex Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Athenex Recent Developments
11.9 BD RX
11.9.1 BD RX Corporation Information
11.9.2 BD RX Overview
11.9.3 BD RX Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 BD RX Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BD RX Recent Developments
11.10 Fosun Pharma
11.10.1 Fosun Pharma Corporation Information
11.10.2 Fosun Pharma Overview
11.10.3 Fosun Pharma Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Fosun Pharma Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Fosun Pharma Recent Developments
11.11 Virtus Pharmaceuticals
11.11.1 Virtus Pharmaceuticals Corporation Information
11.11.2 Virtus Pharmaceuticals Overview
11.11.3 Virtus Pharmaceuticals Ketorolac Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Virtus Pharmaceuticals Ketorolac Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Virtus Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ketorolac Injection Industry Chain Analysis
12.2 Ketorolac Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ketorolac Injection Production Mode & Process
12.4 Ketorolac Injection Sales and Marketing
12.4.1 Ketorolac Injection Sales Channels
12.4.2 Ketorolac Injection Distributors
12.5 Ketorolac Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ketorolac Injection Industry Trends
13.2 Ketorolac Injection Market Drivers
13.3 Ketorolac Injection Market Challenges
13.4 Ketorolac Injection Market Restraints
14 Key Findings in The Global Ketorolac Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer